Für die Filterung wurden keine Ergebnisse gefunden!
NEU
Cas9 Lentivirus (Hygromycin Selection) Artikelnummer: BPS-78067
Cas9 Lentivirus can be used to generate Cas9 expressing cells in almost any mammalian cell line. Cells stably expressing Cas9 can then be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines. The Cas9 Lentiviruses are replication incompetent,...
| Schlagworte: | SpCas9, SpyCas9, SPy_1046, CRISPR-associated endonuclease Cas9/Csn1 |
| Anwendung: | Transient Cas9 expression, Stable Cas9 over-expressing cell line generation (hygromycin selection) |
998,00 €
NEU
COVID-19 Forschung
Spike (B.1.1.7 Variant) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78158-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
NEU
COVID-19 Forschung
Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78143-1
The Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank Accession #QHD43416.1 with mutations K417T, E484K, and N501Y) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
NEU
COVID-19 Forschung
Spike (P.1 Variant) (SARS-CoV-2) Pseudotyped Lentivirus... Artikelnummer: BPS-78144-1
In Brazil, a variant called P.1 was first identified in the summer of 2020. This variant has many mutations that may lead to higher transmissibility and infectivity. The Spike (P.1) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank #QHD43416.1 with P.1 mutations (L18F, T20N,...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
NEU
COVID-19 Forschung
Spike (P.1 Variant) (SARS-CoV-2) Pseudotyped Lentivirus... Artikelnummer: BPS-78159-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
NEU
NF-kappaB eGFP Reporter Lentivirus Artikelnummer: BPS-79926
The NF-kappaB eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced GFP gene driven by the NF-kappaB response element located...
| Schlagworte: | RELA, NFKB3, Transcription factor p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide... |
| Anwendung: | NFkB signaling pathway activator/inhibitor screening, NFkB eGFP reporter stable cell line generation |
| Reaktivität: | Human |
998,00 €
NEU
Negative Control eGFP Reporter Lentivirus Artikelnummer: BPS-79927
The Negative Control eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced Green Fluorescent Protein (eGFP) gene under the...
| Schlagworte: | GFP, Green fluorescent protein |
| Anwendung: | EGFP reporter activity background determination, Establishing lentivirus reporter system specificity |
| Reaktivität: | Mammalian |
998,00 €
NEU
COVID-19 Forschung
Spike (B.1.351 Variant) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78160-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
COVID-19 Forschung
Spike (SARS-CoV-2, B.1.1.7 Variant) Pseudotyped... Artikelnummer: BPS-78112-1
The Spike (SARS-CoV-2, UK variant) Pseudotyped Lentivirus were produced with SARS-CoV-2 UK Variant Spike (Genbank Accession #QHD43416.1 with UK variant mutations, see below for details) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
Anti-CD19 CAR Lentivirus (CD19 SCFV-CD28-4-1BB-CD3zeta) Artikelnummer: BPS-79851-1
The anti-CD19 CAR lentivirus product is ready-to-use, high titer lentiviral particles of anti-CD19 scFv linked to 3rd generation CAR (Chimeric Antigen Receptor) containing CD28, 4-1BB, and CD3zeta signaling domains. The anti-CD19 CAR Lentivirus can be used to transduce nearly all types of mammalian cells, including...
| Schlagworte: | CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen B4 |
| Anwendung: | Primary T cell transduction, CART design specificity, Efficacy, Potency validation, Antibody screening |
| Reaktivität: | Human |
ab 998,00 €
COVID-19 Forschung
Spike(SARS-CoV-2) Pseudotyped Lentivirus (Luc-eGFP Dual... Artikelnummer: BPS-79982-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction mechanism studies, SARS-CoV-2 Spike, ACE2 binding neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 1.245,00 €
COVID-19 Forschung
Spike (SARS-CoV-2) Lentivirus Artikelnummer: BPS-78010-1
Cell entry of SARS-CoV-2 depends on the binding of viral spike protein to cellular receptor ACE2. The SARS-CoV-2 Spike Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing...
| Schlagworte: | 2 |
| Anwendung: | Transient knock-down, Stable knock-out cell generation |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €